Answers are grounded in this paper and cite their sources.
Merkel-cell-carcinoma of the hand is rare. The Pathological and Immunohistochemical diagnosis helps us to focus the treatment. Immunotherapy has shown beneficial effects in unresectable/advanced/metastatic stages. The quantification of antibodies against Merkel-cell-polyomavirus (MCPyV) can be a useful for prognosis and follow-up. A wide margin in surgery and the sentinel node are the first option with Radiotherapy.
No takes yet. Share an insight, caveat, or question.
Mesa et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: